MAFLD
Clinical trials for MAFLD explained in plain language.
Never miss a new study
Get alerted when new MAFLD trials appear
Sign up with your email to follow new studies for MAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Reishi mushroom tested as fatty liver treatment in new study
Disease control ENROLLING_BY_INVITATIONThis study tests whether Ganoderma lucidum (a type of mushroom) can improve antioxidant levels and liver health in people with Metabolic Associated Fatty Liver Disease (MAFLD). Forty adults aged 35-49 with early-stage fatty liver will take the mushroom supplement. Researchers wil…
Matched conditions: MAFLD
Phase: NA • Sponsor: University of Agriculture, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Fatty liver drug hope: semaglutide shows promise in Long-Term study
Disease control OngoingThis study looks at how well the diabetes drug semaglutide works for people with metabolic fatty liver disease (MAFLD) and liver scarring. About 70 adults will take the drug for 3 years as part of their regular care. The goal is to see if it can reduce liver fat, inflammation, an…
Matched conditions: MAFLD
Sponsor: Center of target therapy • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC